Pharming Group N.V. (PHAR) Gross profit 2019–2025
Pharming Group N.V. (PHAR) annual gross profit history from SEC filings — each fiscal year as reported.
$330.6MFY2025 · since FY2019: $165.5M → $330.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $330.6M | +26.3% |
| FY2024 | $261.8M | +18.9% |
| FY2023 | $220.1M | +17.0% |
| FY2022 | $188.1M | +5.8% |
| FY2021 | $177.7M | -5.8% |
| FY2020 | $188.6M | +14.0% |
| FY2019 | $165.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice